Alex R. Menter

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

Bert H. O’Neil, Aaron J. Scott, W.W. Ma et al. · Annals of Oncology · 2015 · 140 citations · Full text

Oncology, Pancreatic Cancer, Gastrointestinal Oncology +9

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices

Scott D. Ramsey, Joseph M. Unger, Laurence H. Baker et al. · JAMA Oncology · 2019 · 87 citations · Full text

Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer

Alex R. Menter, Nikki M. Carroll, Lori C. Sakoda et al. · Clinical Lung Cancer · 2016 · 36 citations · Full text

Oncology, Medicine, Metronomic Therapy +7

Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples

Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga et al. · JCO Precision Oncology · 2021 · 33 citations · Full text